• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

L-天冬酰胺酶治疗急性淋巴细胞白血病对血浆维生素K依赖的凝血因子及抑制剂的影响

Effect of L-asparaginase therapy for acute lymphoblastic leukemia on plasma vitamin K-dependent coagulation factors and inhibitors.

作者信息

Bezeaud A, Drouet L, Leverger G, Griffin J H, Guillin M C

出版信息

J Pediatr. 1986 May;108(5 Pt 1):698-701. doi: 10.1016/s0022-3476(86)81044-7.

DOI:10.1016/s0022-3476(86)81044-7
PMID:2939229
Abstract

Vitamin K-dependent proteins were measured sequentially by immunoassay in eight patients with acute lymphoblastic leukemia receiving L-asparaginase (1000 U/kg/day) for 10 days as induction therapy, in combination with vincristine or vindesine, daunorubicin, cyclophosphamide, and prednisone. The level of each protein was significantly decreased during L-asparaginase therapy, but both the time course of change and the severity of decrease differed among the proteins. The decrease in protein C, factor IX, and factor X was observed earlier than the decrease in protein S and factor II. In the first days of L-asparaginase therapy the protein C level was significantly lower than those of the other vitamin K-dependent proteins. The transient imbalance in the levels of plasma vitamin K-dependent proteins observed in the first days of treatment may contribute to the risk of thrombosis associated with L-asparaginase therapy.

摘要

对8例接受L-天冬酰胺酶(1000 U/kg/天)治疗10天作为诱导疗法的急性淋巴细胞白血病患者,采用免疫分析法依次测定维生素K依赖蛋白,这些患者同时接受长春新碱或长春地辛、柔红霉素、环磷酰胺和泼尼松治疗。在L-天冬酰胺酶治疗期间,每种蛋白的水平均显著降低,但各蛋白的变化时间进程和降低程度有所不同。蛋白C、因子IX和因子X的降低比蛋白S和因子II的降低出现得更早。在L-天冬酰胺酶治疗的最初几天,蛋白C水平显著低于其他维生素K依赖蛋白。治疗最初几天观察到的血浆维生素K依赖蛋白水平的短暂失衡可能会增加与L-天冬酰胺酶治疗相关的血栓形成风险。

相似文献

1
Effect of L-asparaginase therapy for acute lymphoblastic leukemia on plasma vitamin K-dependent coagulation factors and inhibitors.L-天冬酰胺酶治疗急性淋巴细胞白血病对血浆维生素K依赖的凝血因子及抑制剂的影响
J Pediatr. 1986 May;108(5 Pt 1):698-701. doi: 10.1016/s0022-3476(86)81044-7.
2
Lack of pathogenetic role of proteins C and S in thrombosis associated with asparaginase-prednisone-vincristine therapy for leukaemia.蛋白C和蛋白S在白血病天冬酰胺酶-泼尼松-长春新碱治疗相关血栓形成中无致病作用。
Br J Haematol. 1986 Oct;64(2):283-90. doi: 10.1111/j.1365-2141.1986.tb04121.x.
3
The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia.
J Pediatr. 1982 Jun;100(6):990-5. doi: 10.1016/s0022-3476(82)80536-2.
4
Minimal effects of E. coli and Erwinia asparaginase on the coagulation system in childhood acute lymphoblastic leukemia: a randomized study.大肠杆菌和欧文氏菌天冬酰胺酶对儿童急性淋巴细胞白血病凝血系统的影响极小:一项随机研究。
Med Pediatr Oncol. 1994;23(4):335-43. doi: 10.1002/mpo.2950230404.
5
Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.剂量降低的Medac L-天冬酰胺酶对ALL-BFM 2000试验中凝血功能的影响。
Klin Padiatr. 2003 Nov-Dec;215(6):321-6. doi: 10.1055/s-2003-45497.
6
L-asparaginase treatment reduces the anticoagulant potential of the protein C system without affecting vitamin K-dependent carboxylation.L-天冬酰胺酶治疗可降低蛋白C系统的抗凝潜力,而不影响维生素K依赖的羧化作用。
Thromb Res. 1990 Sep 15;59(6):985-94. doi: 10.1016/0049-3848(90)90122-s.
7
L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.左旋门冬酰胺酶、长春新碱和泼尼松用于诱导急性淋巴细胞白血病首次缓解。
Cancer Res. 1977 Feb;37(2):535-40.
8
L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.左旋天冬酰胺酶与年龄对儿童急性淋巴细胞白血病凝血和纤维蛋白溶解的影响
Thromb Haemost. 2008 Aug;100(2):330-7.
9
Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapse.
Cancer. 1978 Feb;41(2):428-34. doi: 10.1002/1097-0142(197802)41:2<428::aid-cncr2820410208>3.0.co;2-c.
10
Greater decrease of fibrinogen as compared to antithrombin III in L-asparaginase treated leukemia patients.在接受L-天冬酰胺酶治疗的白血病患者中,纤维蛋白原的降低幅度大于抗凝血酶III。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(5):663-9.

引用本文的文献

1
Epidemiology, Pathophysiology, and Management of Cancer-Associated Ischemic Stroke.癌症相关性缺血性卒中的流行病学、病理生理学及管理
Cancers (Basel). 2024 Nov 29;16(23):4016. doi: 10.3390/cancers16234016.
2
Unlabelled LRET biosensor based on double-stranded DNA for the detection of anthraquinone anticancer drugs.基于双链DNA的无标记LRET生物传感器用于检测蒽醌类抗癌药物。
Mikrochim Acta. 2023 Dec 13;191(1):15. doi: 10.1007/s00604-023-06076-4.
3
Acquired Clotting Factor Deficits During Treatment with Asparaginase in an Institutional Cohort.
机构队列中接受天冬酰胺酶治疗期间获得性凝血因子缺乏症
J Blood Med. 2023 Nov 7;14:569-574. doi: 10.2147/JBM.S428159. eCollection 2023.
4
Challenges in Management of VTE in Children With Cancer: Risk Factors and Treatment Options.癌症患儿静脉血栓栓塞症管理中的挑战:风险因素与治疗选择
Front Pediatr. 2022 Apr 7;10:855162. doi: 10.3389/fped.2022.855162. eCollection 2022.
5
Cancer Therapy-Associated Thrombosis.癌症治疗相关的血栓。
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1291-1305. doi: 10.1161/ATVBAHA.120.314378. Epub 2021 Feb 11.
6
Cancer-Associated Thrombosis: Risk Factors, Molecular Mechanisms, Future Management.癌症相关性血栓形成:危险因素、分子机制与未来管理。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620954282. doi: 10.1177/1076029620954282.
7
Approach to chemotherapy-associated thrombosis.化疗相关性血栓形成的处理方法
Vasc Med. 2015 Apr;20(2):153-61. doi: 10.1177/1358863X14568705.
8
Subacute leukoencephalopathy complicating acute lymphoblastic leukemia.亚急性白质脑病并发急性淋巴细胞白血病
West J Med. 1987 Feb;146(2):207-12.
9
Effects of the antileukemic drug L-asparaginase on sex hormone-binding globulin: studies in vivo and in vitro.
J Endocrinol Invest. 1989 Jul-Aug;12(7):489-93. doi: 10.1007/BF03350741.